Family Medicine Doctors in Vergennes, VT Accepting Medicare
6 Family Medicine doctors found. Showing 1 - 6
 Dylan Estes, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 North St, Vergennes, VT 05491 Phone: 802-211-3466 |
 Mrs. Jennifer Sandra Kaufman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 10 North Street, Lcfp, Vergennes, VT 05491 Phone: 802-877-3466 Fax: 802-388-8899 |
Dr. Catherine Anne Ayers, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 North St, Vergennes, VT 05491 Phone: 802-877-3466 |
Dr. Daniel C Huber, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 North St, Vergennes, VT 05491 Phone: 802-877-3466 Fax: 802-877-1188 |
Donald Bruce Robinson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 10 North Street, Little City Family Practice, Vergennes, VT 05491 Phone: 802-877-3466 |
Timothy D Bicknell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 North St, Vergennes, VT 05491 Phone: 802-877-3466 Fax: 802-877-1188 |
News Archive
Eating competence may lower risk of heart disease
People who are confident, comfortable and flexible with their eating habits may be at a significantly lower risk of cardiovascular disease than people who are not.
Mount Sinai researcher awarded $2.5 million to advance understanding of neurodegenerative diseases
Ivan Marazzi, PhD, Assistant Professor of Microbiology at the Icahn School of Medicine at Mount Sinai, was awarded $2.5 million in funding by the Chan Zuckerberg Initiative to further the understanding of the underlying causes of neurodegenerative disorders such as Lou Gehrig's, Alzheimer's, and Parkinson's diseases. The
Mylan's generic Doryx ANDA receives final FDA approval
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Hyclate Delayed-release (DR) Tablets USP, 150 mg. This product is the generic version of Mayne Pharma's Doryx, which is a tetracycline-class antimicrobial.
Aeterna Zentaris to present poster on AEZS-130 growth hormone secretagogue/ghrelin receptor agonist at 92nd ENDO
Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, will be presented at the upcoming 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which will be held June 19 through 22, 2010 at the San Diego Convention Center in San Diego, California.
› Verified 7 days ago